Massive hepatic necrosis-associated acute liver failure

TL;DR

This paper discusses severe liver failure caused by massive liver cell death and highlights the role of liver progenitor cells in recovery.

Contribution

The paper reviews recent advances in liver progenitor cell biology in the context of massive hepatic necrosis-associated acute liver failure.

Findings

Massive hepatic necrosis is linked to higher mortality in acute liver failure.

Liver progenitor cells are crucial for regeneration after massive hepatic necrosis.

MHN-associated ALF differs from other liver failure types in its regenerative mechanisms.

Abstract

Massive hepatic necrosis (MHN), characterised by extensive loss of hepatocytes, represents the most severe pathological lesion in acute liver failure (ALF). MHN-associated ALF primarily occurs in patients with acute viral hepatitis A, B or E infections. Additionally, MHN-associated ALF can develop in patients with autoimmune hepatitis or in those taking idiosyncratic drugs. MHN-associated ALF is associated with significantly higher mortality than that caused by other aetiologies. In contrast to other forms of ALF, liver regeneration following MHN depends on liver progenitor cells (LPCs)—the smallest cholangiocytes localising in the canal of Hering and terminal biliary branches. These cells play key roles in determining the clinical outcome of patients with MHN-associated ALF. This paper reviews the pathophysiology of MHN-associated ALF and recent advances in LPC biology.

Figures